Christopher Simon
Pharmaceutical
Haemonetics Corp
United States of America
Biography
Mr. Christopher Simon, also known as Chris, has been the Chief Executive Officer and President of Haemonetics Corporation since May 16, 2016. Mr. Simon serves as a Senior Partner and Leader at McKinsey & Company's Pharmaceutical and Medical Products Practice in North America and leads its work on medical products globally. He has been with McKinsey & Company since 1993. He has served as Regional Operations Manager at Baxter Healthcare. Mr. Simon has led various domestic and global engagements for a leading pharmaceutical manufacturer that included the development of growth and capabilities strategy for launching multiple products, licensing and acquisition strategy, marketing strategy for global product lifecycle management, and redesign of development capabilities for a diversified med tech manufacturer with the aim of reducing time to market, improving regulatory affairs and accelerating product launch. He served as an Infantry Officer with the United States Army’s 1st Ranger Battalion. He has considerable experience in addressing strategic and operational issues in pharmaceuticals, biotechnology, diversified health care services companies, and medical device manufacturers. For nearly 20 years, he has worked with clients in healthcare and consumer goods. He serves as a Director of McKinsey & Company. He has been a Director of Haemonetics Corporation since September 12, 2016. Mr. Simon served as a Member of Advisory Board at Safeguard Scientifics, Inc. since April 2006 and served as its Member of Life Sciences Advisory Board. Mr. Simon earned an M.B.A. degree with distinction from Harvard Business School and B.S. in Economics magna cum laude from the University of Pennsylvania, where he majored in Finance and Decision Sciences
Research Interest
Business